About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00525499

A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris

The purpose of this study is to evaluate if topical ASC-J9 cream is effective in treating acne.

Lead sponsor: AndroScience Corp•10 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

AndroScience Corp

Subjects with acne were randomized to one of four treatment groups for twice daily topical dosing to the face for 12 weeks. Assessments of acne status were performed at Baseline, Weeks 2, 4, 8 and 12 and then 4 weeks after the last dose of study drug.

Age

12 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•At least 12 years of age.
•Facial acne, with:
•20 -100 inflammatory facial lesions 20 -100 noninflammatory facial lesions No more than 2 nodules/cysts on the face

Exclusion Criteria

•Women who are pregnant or breastfeeding
•Skin diseases other than acne vulgaris
•Use of oral retinoids within 6 months of Baseline Visit
•Unwilling to discontinue all other treatments for facial acne
•Unwilling to avoid excessive swimming/sun exposure and use of cosmetics

Related studies

Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris

NCT07205107 · Acne Vulgaris

RECRUITINGEARLY Phase 1

Weekly Isotretinoin vs Tetracycline for Moderate Acne

NCT06225570 · Acne Vulgaris

RECRUITINGPhase 1/2

Clascoterone for Steroid-related Acne Vulgaris in Transgender Male Patients Receiving Masculinizing Hormone Therapy

NCT05891795 · Acne Vulgaris

Vitamin D Supplementation in Acne

NCT06141330 · Acne Vulgaris

Profiles Analysis of Genome Wide Association Study (GWAS) in Acne Vulgaris in Indonesia.

NCT06501560 · Acne Vulgaris

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 23, 2011Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment186

Start dateAug 2007

Last updatedNov 23, 2011

Condition

Locations shown

East Bay Dermatology Medical Group

Fremont, California

Therapeutics Clinical Research

San Diego, California

Northwest Clinical Trial

Boise, Idaho

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 23, 2011Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions